Literature DB >> 23624300

Label retaining cells in cancer--the dormant root of evil?

Anja Schillert1, Andreas Trumpp, Martin R Sprick.   

Abstract

The phenomenon of cellular dormancy has been observed in normal adult stem cells in many different tissues such as the skin, the intestine and the hematopoietic system. These dormant cells have been proposed to be important for life-long self-renewal and for the generation of the different cellular lineages. As tumor cells can share properties with normal stem cells, dormant cells might also exist within a tumor. The term tumor dormancy has evolved from the clinical observation in cancer patients that relapse can occur years to decades after apparently successful treatment, suggesting that some cancer cells might resist chemotherapy and persist in a dormant state. Several studies investigating the role of cellular dormancy in normal stem cells and in cancer hint towards a complex network involving different pools of cells. These cells might interact with each other or even dynamically switch their phenotypes dependent upon so far unknown endogenous and microenvironmental stimuli. In this review, we will discuss the recent findings related to cellular dormancy in normal adult stem cells and in cancer. Furthermore, the clinical relevance of dormancy and its dynamic regulation in tumor cells will be highlighted.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Cellular plasticity; Disseminated tumor cells; Dormancy; Stem cells; Tumor relapse

Mesh:

Year:  2013        PMID: 23624300     DOI: 10.1016/j.canlet.2013.04.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Differential Sensitivities of Fast- and Slow-Cycling Cancer Cells to Inosine Monophosphate Dehydrogenase 2 Inhibition by Mycophenolic Acid.

Authors:  Kan Chen; Wanlu Cao; Juan Li; Dave Sprengers; Pratika Y Hernanda; Xiangdong Kong; Luc Jw van der Laan; Kwan Man; Jaap Kwekkeboom; Herold J Metselaar; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Mol Med       Date:  2015-10-13       Impact factor: 6.354

2.  Growth inhibitory effects of large subunit ribosomal proteins in melanoma.

Authors:  Gregory R Kardos; Mu-Shui Dai; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2014-06-16       Impact factor: 4.693

3.  Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype.

Authors:  Anne-Marie Bleau; Carolina Zandueta; Miriam Redrado; Susana Martínez-Canarias; Leyre Larzábal; Luis M Montuenga; Alfonso Calvo; Fernando Lecanda
Journal:  Oncotarget       Date:  2015-09-29

4.  Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia.

Authors:  Sarah Ebinger; Erbey Ziya Özdemir; Christoph Ziegenhain; Sebastian Tiedt; Catarina Castro Alves; Michaela Grunert; Michael Dworzak; Christoph Lutz; Virginia A Turati; Tariq Enver; Hans-Peter Horny; Karl Sotlar; Swati Parekh; Karsten Spiekermann; Wolfgang Hiddemann; Aloys Schepers; Bernhard Polzer; Stefan Kirsch; Martin Hoffmann; Bettina Knapp; Jan Hasenauer; Heike Pfeifer; Renate Panzer-Grümayer; Wolfgang Enard; Olivier Gires; Irmela Jeremias
Journal:  Cancer Cell       Date:  2016-12-01       Impact factor: 31.743

5.  Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells.

Authors:  Dandan Li; John E Mullinax; Taylor Aiken; Hongwu Xin; Gordon Wiegand; Andrew Anderson; Snorri Thorgeirsson; Itzhak Avital; Udo Rudloff
Journal:  BMC Cancer       Date:  2018-07-31       Impact factor: 4.430

6.  Aggressiveness Potential of Spontaneous Canine Mucosal Melanoma Can Dictate Distinct Cancer Stem Cell Compartment Behaviors in Regard to Their Initial Size and Expansion Abilities.

Authors:  Yasmine Touil; Zacharie Segaoula; Xavier Thuru; Sylvie Galiègue-Zouitina; Dominique Tierny; Bruno Quesnel
Journal:  Stem Cells Dev       Date:  2020-06-22       Impact factor: 3.272

Review 7.  Stem cell quiescence: the challenging path to activation.

Authors:  Noelia Urbán; Tom H Cheung
Journal:  Development       Date:  2021-02-08       Impact factor: 6.868

8.  Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target.

Authors:  Bogdan Domrachev; Sitanshu Singh; Dandan Li; Udo Rudloff
Journal:  J Cancer Treatment Diagn       Date:  2021-04-30

9.  Label-retaining assay enriches tumor-initiating cells in glioblastoma spheres cultivated in serum-free medium.

Authors:  Lingcheng Zeng; Yiqing Zhao; Taohui Ouyang; Tianyuan Zhao; Suojun Zhang; Jian Chen; Jiasheng Yu; Ting Lei
Journal:  Oncol Lett       Date:  2016-06-08       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.